Foreign journals publish Amosartan

Published: 2012-02-23 06:57:00

Updated: 2012-02-23 06:57:00

Hanmi’s anti-hypertension fixed-dose combination, Amosartan (amolodipine + Losartan), was published in international peer-reviewed journals, such as BMC (BioMed Central Research Notes) and AJCD (American Journal of Cardiovascular Drugs).

According to the results of Phase II study of 320 hypert...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK